Company Overview
Snapshot
Founded in October 2014 by Amir Kraitzer, Earways Medical operates with 1–10 employees. The company has secured funding across two rounds from ExitValley. In January 2018, Earways Medical received equity crowdfunding from ExitValley.
Business overview
Earways Medical is a Health Tech & Life Sciences company focused on developing clinically proven ear care solutions. The company's core products, EarWay Pro and EarWay HomeCare, are designed to facilitate simple cerumen extraction and manage earwax accumulation and impaction. Earways Medical serves healthcare professionals and home users, operating within the Digital Healthcare sector, specifically targeting Digital Therapeutics, and addressing consumers including children and seniors.
Strategic signal
In August 2020, Earways Medical partnered with AuDNet to market its EarWay Pro earwax removal tool in the US. This strategic collaboration indicates the company's focus on expanding its market reach and strengthening its distribution channels for its medical devices in a key market, signaling potential for increased product adoption and revenue growth.
Company Intelligence Q&A
- What is Earways Medical's primary focus?
- Earways Medical develops clinically proven ear care solutions for healthcare professionals and for use at home, focusing on products like EarWay Pro and EarWay HomeCare for cerumen extraction and earwax management.
- When was Earways Medical founded and by whom?
- Earways Medical was founded in October 2014 by Amir Kraitzer.
- Has Earways Medical secured any funding?
- Yes, Earways Medical received equity crowdfunding from ExitValley in January 2018. The company has secured funding across two rounds.
- What significant partnership did Earways Medical announce in 2020?
- In August 2020, Earways Medical partnered with AuDNet to market the EarWay Pro earwax removal tool in the US.
- What other partnership did Earways Medical establish in 2020?
- In February 2020, Sanibel Supply partnered with Earways Medical to market its products.